Citations 1
729 A first-in-human, open-label, multicenter, phase 1/2a, dose escalation and expansion study of GI-102, a novel immunocytokine combining CD80-IL2v3, in patients with advanced or metastatic solid tumors
Lee, Jeeyun , Campian, Jian , Zhao, Yujie , Seetharam, Mahesh , Adjei, Alex A. , Yun, Nari, Lee, Woo-Sun, Lee, Wooyul, Park, Sosun, Seo, Bochan, Lee, Kyungwha, Park, Chong Woo, Cho, Byoung Chul , Lee, Jae‐Lyun , Lee, Jung-Yun , Wee, Wen , Chae, Dongwoo , Jang, Myoung Ho
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A824-A824
